High Protein Group Research Articles

Effect of Increased Enteral Protein Intake on Growth in Human Milk–Fed Preterm Infants

Protein, supplied in currently available commercial fortifiers, may be inadequate to meet the requirements of very preterm infants; in addition, intraindividual and interindividual variability of human milk protein and energy content potentially contribute to unsatisfactory early postnatal growth. To determine effects on growth of different levels of enteral protein supplementation in predominantly human milk-fed preterm infants. This randomized clinical and partially blinded single-center trial was conducted in a neonatal tertiary referral center in Germany. Sixty preterm infants (gestation <32 weeks and weight <1500 g at birth) were recruited from October 2012 to October 2014 and included 35% of 173 eligible infants. Median (interquartile range [IQR]) gestational age at birth was 29.9 (28.7-31.2) weeks. All analyses were conducted in an intention-to-treat population. Infants were randomly assigned to either a lower-protein (adding 1 g of bovine protein/100 mL of breast milk through a commercial human milk fortifier; n = 30) or a higher-protein group at a median (IQR) postnatal age of 7 (6-8) days. The higher-protein group (n = 30) received either standardized higher-protein supplementation (study fortifier adding 1.8 g of bovine protein/100 mL of breast milk [n = 15]) or individualized high-protein supplementation based on protein and fat content of administered breast milk (n = 15). Study interventions were continued for a median (IQR) of 41 (30-57) days and until definite discharge planning. Primary outcome was weight gain (g/kg/d) from birth to the end of intervention. Sixty preterm infants (gestation <32 weeks and weight <1500 g at birth), 33 girls, were recruited from October 2012 to October 2014 and included 35% of 173 eligible infants. Median (IQR) gestational age at birth was 29.9 (28.7-31.2) weeks. Demographic characteristics and hospital courses were similar in both groups, and birth weights ranged from 580 to 1495 g in the lower-protein group and 490 to 1470 g in the higher-protein group. Weight gain was similar in the lower- and higher-protein groups: mean (95% CI), 16.3 g/kg/d (15.4-17.1 g/kg/d) in the lower-protein group vs 16.0 g/kg/d (15.1-16.9 g/kg/d) in the higher-protein group) (P = .70), despite an increase in actual protein intake by 0.6 g/kg/d (0.4-0.7 g/kg/d) (P < .001). Head circumference and lower leg longitudinal growth were also similar, as was the proportion of cumulative total enteral feeding volume provided as breast milk: median (IQR) proportion of breast milk, 92% (79%-98%) in the lower-protein group vs 94% (62%-99%) in the higher-protein group (P = .89). An increase in protein intake by 0.6 g/kg/d to a mean intake of 4.3 g/kg/d did not further enhance growth of very preterm infants with a median birth weight of 1200 g, who achieved near-fetal growth rates. This might point to a ceiling effect for enteral protein intake with respect to its influence on growth. clinicaltrials.gov Identifier: NCT01773902.

Mixed compared with single-source proteins in high-protein diets affect kidney structure and function differentially in obesefa/faZucker rats

Questions remain regarding the potential negative effects of dietary high protein (HP) on kidney health, particularly in the context of obesity in which the risk for renal disease is already increased. To examine whether some of the variability in HP effects on kidney health may be due to source of protein, obese fa/fa Zucker rats were given HP (35% of energy from protein) diets containing either casein, soy protein, or a mixed source of animal and plant proteins for 12 weeks. Control lean and obese rats were given diets containing casein at normal protein (15% of energy from protein) levels. Body weight and blood pressure were measured, and markers of renal structural changes, damage, and function were assessed. Obesity alone resulted in mild renal changes, as evidenced by higher kidney weights, proteinuria, and glomerular volumes. In obese rats, increasing the protein level using the single, but not mixed, protein sources resulted in higher renal fibrosis compared with the lean rats. The mixed-protein HP group also had lower levels of serum monocyte chemoattractant protein-1, even though this diet further increased kidney and glomerular size. Soy and mixed-protein HP diets also resulted in a small number of damaged glomeruli, while soy compared with mixed-protein HP diet delayed the increase in blood pressure over time. Since obesity itself confers added risk of renal disease, an HP diet from mixed-protein sources that enables weight loss but has fewer risks to renal health may be advantageous.

Dietary macronutrient composition affects hypothalamic appetite regulation in chicks

Objective: The objective was to determine the effects of high-protein and high-fat diets, and fasting and refeeding, on appetite regulation in chicks.Methods: Day of hatch chicks were fed one of four diets: basal, high protein (25% crude protein), and 15 and 30% high fat (15 and 30% metabolizable energy derived from soybean oil, respectively), and assigned to one of three treatments at 4 days: (1) access to feed, (2) 3 hours of fasting, or (3) fasting followed by 1 hour of refeeding. The hypothalamus was collected, total RNA isolated, and mRNA abundance measured.Results: Food intake was reduced in chicks fed the high-protein and high-fat diets. Agouti-related peptide, neuropeptide Y (NPY), NPY receptors 1, 2, and 5, melanocortin receptors 3 and 4 (MC3R and 4R, respectively), mesotocin, corticotropin-releasing factor (CRF), and CRF receptor sub-type 2 (CRFR2) mRNAs were greatest in chicks that consumed the basal diet. Refeeding was associated with increased MC3R mRNA in the high-protein diet group. CRFR2 mRNA was increased by fasting and refeeding in chicks that consumed the high-protein diet.Discussion: Food intake and hypothalamic gene expression of some important appetite-associated factors were reduced in chicks fed the high-protein or high-fat diets. Fasting and refeeding accentuated several differences and results suggest that the CRF and melanocortin pathways are involved.

Effects of Dietary Fibre (Pectin) and/or Increased Protein (Casein or Pea) on Satiety, Body Weight, Adiposity and Caecal Fermentation in High Fat Diet-Induced Obese Rats.

Dietary constituents that suppress appetite, such as dietary fibre and protein, may aid weight loss in obesity. The soluble fermentable dietary fibre pectin promotes satiety and decreases adiposity in diet-induced obese rats but effects of increased protein are unknown. Adult diet-induced obese rats reared on high fat diet (45% energy from fat) were given experimental diets ad libitum for 4 weeks (n = 8/group): high fat control, high fat with high protein (40% energy) as casein or pea protein, or these diets with added 10% w/w pectin. Dietary pectin, but not high protein, decreased food intake by 23% and induced 23% body fat loss, leading to 12% lower final body weight and 44% lower total body fat mass than controls. Plasma concentrations of satiety hormones PYY and total GLP-1 were increased by dietary pectin (168% and 151%, respectively) but not by high protein. Plasma leptin was decreased by 62% on pectin diets and 38% on high pea (but not casein) protein, while plasma insulin was decreased by 44% on pectin, 38% on high pea and 18% on high casein protein diets. Caecal weight and short-chain fatty acid concentrations in the caecum were increased in pectin-fed and high pea protein groups: caecal succinate was increased by pectin (900%), acetate and propionate by pectin (123% and 118%, respectively) and pea protein (147% and 144%, respectively), and butyrate only by pea protein (309%). Caecal branched-chain fatty acid concentrations were decreased by pectin (down 78%) but increased by pea protein (164%). Therefore, the soluble fermentable fibre pectin appeared more effective than high protein for increasing satiety and decreasing caloric intake and adiposity while on high fat diet, and produced a fermentation environment more likely to promote hindgut health. Altogether these data indicate that high fibre may be better than high protein for weight (fat) loss in obesity.

Effects of a higher vs. lower protein diet on weight loss in teenagers: Results from a randomized controlled trial

ObjectiveTo provide pilot data on weight loss efficacy in overweight and obese adolescents during isocaloric lower vs higher protein weight loss diets utilizing the U.S. Department of Agriculture (USDA) MyPlate nutrition guide.MethodsThirty two, 12–17 year old adolescents with body mass index ≥ 85th percentile were recruited for a 12‐week free‐living weight loss intervention. Participants were randomized to either a lower protein group with 15% of energy as protein and 60% of energy from carbohydrate or a higher protein group with 30% of energy as protein and 45% of energy from carbohydrate. Both diets restricted energy intake by 25%. Dietary counseling was based on the USDA MyPlate guidelines. The first intervention session was individual followed by 6 (biweekly) group sessions. Participants had anthropometric measurements and performed retrospective visual analogue scale (VAS) appetite ratings at baseline and week 12.ResultsParticipants were 75 % female and 62.5 % black. The baseline mean (± SD) age, body weight, and BMI z‐score were 14.3 ± 1.5 y, 96.0 ± 21.9 kg, and 2.21 ± 0.48, respectively. The lower protein group reduced BMI z‐score compared to the higher protein group (0.18 ± 0.16 vs. 0.05 ± 0.09; p&lt;0.05). No other group differences were found but fullness tended to increase in the higher protein group (0.5 ± 20.5 vs. 14.9 ± 15.2; p=0.08). Participants lost 3.1 ± 2.0 kg vs. 1.5 ± 4.2 kg body weight and 2.8 ± 2.4 % vs. 3.0 ± 5.2 % body fat in the lower vs. higher protein groups, respectively. The lower protein group change from baseline BMI z‐score, body weight, and body fat were reduced (p≤0.002) but the higher protein group change from baseline values were not different from baseline. Exploratory analyses, with the protein groups combined, indicated that overweight adolescents reduced BMI z‐score 0.38 ± 0.12 compared to 0.07 ± 0.08 in the obese subgroup (p&lt;0.01).ConclusionsParticipants in the higher protein group tended to increase fullness, but this did not translate to greater weight loss. Higher dietary protein intake should not be recommended for weight loss in group based interventions in this study population. An adolescent intervention based on the USDA MyPlate guidelines is efficacious for weight loss in adolescents.Support or Funding InformationNIH U54 GM104940 and NIH P30 DK072476

Effect of supplementation of crystalline lysine on the performance of WL layers in tropics during summer.

A trial was conducted to evaluate the effect of lysine concentration in the diet of WL layers with constant ratio of other essential amino acids to lysine. Pullets (528) aged 25 to 36 weeks were fed with test diet containing two protein levels (13.36 and 15.78%) each with 5% concentration of lysine (0.50, 0.55, 0.60, 0.65, and 0.70) and a control with 17% CP and 0.70%, lysine. Each test diet was fed ad libitum to six replicates of eight birds for a period of 12 weeks. Egg production (EP), egg weight (EW), egg mass (EM), feed efficiency (g/g) (FE), body weight gain (BWG), Haugh unit (HU) and yolk colour (YC) were measured. Increased (P ≤ 0.05) EP, EW, EM, FE and BWG were obtained with increasing lysine concentration in diets. Whereas, feed intake/h/day, feed intake/egg, egg shell defects (ESD), mortality and shell thickness were not affected (P ≥ 0.05) by the concentration of lysine in diet. However, higher (P ≤ 0.05) HU score and YC were noticed at low lysine (0.50 %) concentrations. Based on this, it was concluded that WL layers (25-36 weeks) reared in open-sided houses in the tropics require approximately 0.70 % lysine (597.90 vs. 584.39 mg/h/day) in low (13.36% CP) and high (15.78% CP) protein groups in diets containing approximately 2700 kcal of ME/kg in summer.

The effects of a high protein diet on indices of health and body composition--a crossover trial in resistance-trained men.

BackgroundEight weeks of a high protein diet (>3 g/kg/day) coupled with a periodized heavy resistance training program has been shown to positively affect body composition with no deleterious effects on health. Using a randomized, crossover design, resistance-trained male subjects underwent a 16-week intervention (i.e., two 8-week periods) in which they consumed either their normal (i.e., habitual) or a higher protein diet (>3 g/kg/day). Thus, the purpose of this study was to ascertain if significantly increasing protein intake would affect clinical markers of health (i.e., lipids, kidney function, etc.) as well as performance and body composition in young males with extensive resistance training experience.MethodsTwelve healthy resistance-trained men volunteered for this study (mean ± SD: age 25.9 ± 3.7 years; height 178.0 ± 8.5 cm; years of resistance training experience 7.6 ± 3.6) with 11 subjects completing most of the assessments. In a randomized crossover trial, subjects were tested at baseline and after two 8-week treatment periods (i.e., habitual [normal] diet and high protein diet) for body composition, measures of health (i.e., blood lipids, comprehensive metabolic panel) and performance. Each subject maintained a food diary for the 16-week treatment period (i.e., 8 weeks on their normal or habitual diet and 8 weeks on a high protein diet). Each subject provided a food diary of two weekdays and one weekend day per week. In addition, subjects kept a diary of their training regimen that was used to calculate total work performed.ResultsDuring the normal and high protein phase of the treatment period, subjects consumed 2.6 ± 0.8 and 3.3 ± 0.8 g/kg/day of dietary protein, respectively. The mean protein intake over the 4-month period was 2.9 ± 0.9 g/kg/day. The high protein group consumed significantly more calories and protein (p < 0.05) than the normal protein group. There were no differences in dietary intake between the groups for any other measure. Moreover, there were no significant changes in body composition or markers of health in either group. There were no side effects (i.e., blood lipids, glucose, renal, kidney function etc.) regarding high protein consumption.ConclusionIn resistance-trained young men who do not significantly alter their training regimen, consuming a high protein diet (2.6 to 3.3 g/kg/day) over a 4-month period has no effect on blood lipids or markers of renal and hepatic function. Nor were there any changes in performance or body composition. This is the first crossover trial using resistance-trained subjects in which the elevation of protein intake to over four times the recommended dietary allowance has shown no harmful effects.

Effects of High Protein and Balanced Diets on Lipid Profiles and Inflammation Biomarkers in Obese and Overweight Women at Aerobic Clubs: A Randomized Clinical Trial.

Background:We studied the effects of high protein (HP) and balanced diets (BDs) on lipid profiles, and high-sensitive C-reactive protein (hs-CRP) levels in obese and overweight women.Methods:In a parallel designed randomized controlled clinical trial, 60 healthy women with body mass index ≥25 kg/m2, aged 20–46 years, enrolled in an 8-week investigation at aerobic clubs. They were categorized into two groups (HP and BDs), randomly. Fasting lipid profile and hs-CRP levels were evaluated at the beginning and end of the trial. We assessed dietary intake by 3-day records and also used SPSS (version 18; SPSS Inc., Chicago, IL, USA) for data analyzing.Results:Fifty-six participants completed the intervention. Concentrations of low-density lipoprotein cholesterol (P < 0.001 in BD group vs. P =0.023 in HP group) and high-density lipoprotein cholesterol (P < 0.001 in BD group vs. P =0.002 in HP group) increased significantly in both groups. Circulating triglycerides levels increased in both intervention grows, but the change in the HP group was not significant compared with the other group (P = 0.007 in BD group vs. P =0.099 in HP group). Whereas total cholesterol concentration decreased but not significantly so (P = 0.53 in BD group vs. P =0.73 in HP group). There were marginally significant decreases in the hs-CRP levels due to both diets (P = 0.057 in BD group vs. P =0.086 in HP group); however, there were no significant differences between the groups.Conclusions:Administration of HP and BD in overweight and obese women with regular aerobic exercise showed improvement in lipid profiles and hs-CRP levels within the groups, but there were no significant differences between groups.

Postnatal High Protein Intake Can Contribute to Accelerated Weight Gain of Infants and Increased Obesity Risk.

Worldwide, 38% of women are now overweight (BMI 25-30) or obese (BMI ≥30). There is increasing evidence that maternal obesity can result in unfavorable (epigenetic) pre- and postnatal programming of important genes of the offspring. Infants of overweight mothers show faster weight gain during infancy, which is associated with higher risk of obesity during childhood and adult life. This can have lifelong consequences such as increased risk of noncommunicable diseases. Many studies indicate that infants of obese and nonobese mothers who were fed traditional (high-protein) formulas gain more rapidly weight than breastfed infants. An updated meta-analysis (n = 1,150) indicates that infants from four continents who were fed a whey-based, low-protein (1.8 g/100 kcal) formula with an essential amino-acid profile closer to breast milk grow in accordance with the World Health Organization (WHO) growth standard (0-4 months). A new experimental low-protein (1.61-1.65 g protein/100 kcal) formula for infants between 3 and 12 months of age was recently tested in two randomized clinical trials. One trial in the general US population indicates lower weight between 4 and 12 months of age in infants fed the low-protein formula when compared to infants on the high-protein formula (p = 0.031). Weight gain was not inferior to the WHO growth standards. Longitudinal analysis of odds ratios from 4 to 12 months of age showed a lower incidence of infants with weight >85th percentile in the low-protein group compared with the high-protein group (p = 0.015). In the second trial, which was conducted in Chile and included infants of mothers with BMI >25, infants fed the low-protein formula gained less weight between 4 and 12 months (p = 0.022) and until 24 months (p = 0.031) than the high-protein group. Weight gain was similar to the breastfed reference group. In both trials, biomarkers of protein metabolism (insulin-like growth factor-1 and C-peptide) of the low-protein groups were closer to breastfed infants than the respective biomarkers of the high-protein groups. Health economic analyses indicate that feeding low-protein formulas to nonbreastfed infants would result in cost savings for both the individual and the society. Preventive measures against childhood and adult obesity should include promotion of breastfeeding for 6 months or longer, and use of low-protein formulas in nonbreastfed infants.

Estimation of the 24-h urinary protein excretion based on the estimated urinary creatinine output.

The urinary protein/creatinine ratio [Up/Ucr (g/gCr)] has been used in the clinical management of patients with chronic kidney disease (CKD). However, a discrepancy is often noted between the Up/Ucr and 24-h urinary protein excretion [24hUp (g/day)] in patients with extremes of muscle mass. We examined devised a method for precise estimation of the 24-h urinary protein excretion (E-24hUp) based on estimation of 24-h urinary creatinine output (E-24hCr). Three parameters, spot Up/Ucr, 24hUP and E-24hUp (=Up/Ucr×E-24hCr), were determined in 116 adult patients with CKD. The correlations among the groups were analyzed. There was a significant correlation between the Up/Ucr and 24hUp (p<0.001). We divided the patients into three groups according to the 24hUp; the low urinary protein group (<1.0g/day), the intermediate urinary protein group (1.0-3.5g/day), and the high urinary protein group (>3.5g/day). There was a significant correlation between the Up/Ucr and 24hUp in the low (p=0.04) and high urinary protein (p=0.01) groups, whereas the correlation coefficient was lower in the intermediate urinary protein (p=0.07) group. Thus, we found a significant correlation between 24hUp and E-24hUp in the study population overall (p<0.001), in the low (p=0.01), in the intermediate (p<0.001), and in the high urinary protein group (p<0.001). We conclude that a poor correlation exists between the Up/Ucr and 24hUp in patients with intermediate urinary protein excretion levels. The recommended parameter for monitoring proteinuria in such patients may be the E-24hUp, which is calculated using the E-24hCr.

Changes of high mobility group protein box 1 and interleukin-6 in epileptic children and their significance

Objective To explore the changes of high mobility protein group box 1(HMGB1) and interleukin-6(IL-6) in epileptic patients and discuss the significance. Methods Eighty-five children aged 6 months to 12 years old with idiopathic generalized or partial epilepsy diagnosed in the First Affiliated Hospital of Zhengzhou University as the epileptic group, and it consisted of 20 cases of frequent epilepsy subgroup, 16 cases of status epilepticus subgroup, and 49 cases of non frequent or status epilepticus subgroup.Twenty-five healthy children in outpatient department were selected as the healthy controls.Fasting veinal blood was obtained after seizure within 12 hours.The serum was collected and kept in the -80 ℃ refrigerator.Enzyme linked immunosorbent assay was adopted to investigate the levels of HMGB1 and IL-6 in the serum.The data were analyzed by using SPSS 17.0 software. Results The levels of IL-6 in the serum of frequent epilepsy subgroup, status epilepticus subgroup, non frequent or status epilepticus subgroup and the healthy controls were 14.559 ng/L, 14.752 ng/L, 11.981 ng/L, 8.056 ng/L, respectively, and the levels of HMGB1 were 8 621 ng/L, 8 987 ng/L, 7 870 ng/L, 4 221 ng/L, respectively.The levels of IL-6, HMGB1 of epileptic groups were higher than the healthy controls, especial the levels of IL-6, HMGB1 of frequent epilepsy subgroup and the status epilepticus subgroup were higher than other in non frequent or status epilepticus subgroup, but the levels of IL-6, HMGB1 between epilepsy subgroup and status epilepticus subgroup had no obvious difference(P>0.05). The level of IL-6 had a positive correlation with level of HMGB1(r=0.760, P<0.05). Conclusions It suggests that HMGB1 and the cytokine network may contribute to the generation of epilepsy in children.The inhibitor of HMGB1 and IL-6 play a potential role in treatment of epilepsy. Key words: Epilepsy; Immune inflammation; Interleukin-6; High mobility protein group box 1; Child

Influence of a fermented protein-fortified dairy product on serum insulin-like growth factor-I in women with anorexia nervosa: A randomized controlled trial

Patients with anorexia nervosa (AN) have low serum IGF-I levels that may contribute to a lower bone mineral mass. We investigated the effects of a fermented, protein-fortified, dairy product on serum IGF-I levels in patients with AN during an in-hospital refeeding program. In this multicenter, randomized, double-blind, placebo-controlled, clinical trial conducted at 3 university hospitals and 3 private clinics in France and Switzerland, 62 women recently admitted with confirmed AN and with a baseline low serum IGF-I level were randomized to 2 daily isocaloric fresh cheese pots containing either 15g/150g or 3g/150g (controls) of protein for 4 weeks. The primary outcome was the change in IGF-I levels. In the primary intention-to-treat analysis, mean serum IGF-I levels increased during the intervention phase from 22.9±1.5 to 28.6±1.3nmol/L (means±SEM) (+20.2%) in the intervention group and from 20.2±1.2 to 25.7±1.5nmol/L (+16.8%) in controls. In a preplanned analysis of covariance with repeated measures, the between-group difference was close to statistical significance (P=0.071). In a post-hoc mixed-regression model analysis, the difference was statistically significant (4.9nmol/l increase; P=0.003), as was the change of the ratio IGF-I/IGF-BP3 (P=0.004). There was no between-group difference in biochemical markers of bone turnover (osteocalcin, P1NP, CTX) or in serum parathyroid hormone level. Serum calcium levels slightly increased during the intervention phase in the higher protein group (P=0.02). IGF-BP2 decreased significantly more in the intervention group during the follow up period at week 4 after supplements cessation (P=0.019). Intake of a fermented, protein-fortified, isocaloric dairy product during 4 weeks may slightly increase serum IGF-I levels in women with AN, without significant changes in bone turnover markers. NCT01823822 (www.clinicaltrials.gov).

A high protein diet (3.4 g/kg/d) combined with a heavy resistance training program improves body composition in healthy trained men and women--a follow-up investigation.

BackgroundThe consumption of a high protein diet (>4 g/kg/d) in trained men and women who did not alter their exercise program has been previously shown to have no significant effect on body composition. Thus, the purpose of this investigation was to determine if a high protein diet in conjunction with a periodized heavy resistance training program would affect indices of body composition, performance and health.MethodsForty-eight healthy resistance-trained men and women completed this study (mean ± SD; Normal Protein group [NP n = 17, four female and 13 male]: 24.8 ± 6.9 yr; 174.0 ± 9.5 cm height; 74.7 ± 9.6 kg body weight; 2.4 ± 1.7 yr of training; High Protein group [HP n = 31, seven female and 24 male]: 22.9 ± 3.1 yr; 172.3 ± 7.7 cm; 74.3 ± 12.4 kg; 4.9 ± 4.1 yr of training). Moreover, all subjects participated in a split-routine, periodized heavy resistance-training program. Training and daily diet logs were kept by each subject. Subjects in the NP and HP groups were instructed to consume their baseline (~2 g/kg/d) and >3 g/kg/d of dietary protein, respectively.ResultsSubjects in the NP and HP groups consumed 2.3 and 3.4 g/kg/day of dietary protein during the treatment period. The NP group consumed significantly (p < 0.05) more protein during the treatment period compared to their baseline intake. The HP group consumed more (p < 0.05) total energy and protein during the treatment period compared to their baseline intake. Furthermore, the HP group consumed significantly more (p < 0.05) total calories and protein compared to the NP group. There were significant time by group (p ≤ 0.05) changes in body weight (change: +1.3 ± 1.3 kg NP, −0.1 ± 2.5 HP), fat mass (change: −0.3 ± 2.2 kg NP, −1.7 ± 2.3 HP), and % body fat (change: −0.7 ± 2.8 NP, −2.4 ± 2.9 HP). The NP group gained significantly more body weight than the HP group; however, the HP group experienced a greater decrease in fat mass and % body fat. There was a significant time effect for FFM; however, there was a non-significant time by group effect for FFM (change: +1.5 ± 1.8 NP, +1.5 ± 2.2 HP). Furthermore, a significant time effect (p ≤ 0.05) was seen in both groups vis a vis improvements in maximal strength (i.e., 1-RM squat and bench) vertical jump and pull-ups; however, there were no significant time by group effects (p ≥ 0.05) for all exercise performance measures. Additionally, there were no changes in any of the blood parameters (i.e., basic metabolic panel).ConclusionConsuming a high protein diet (3.4 g/kg/d) in conjunction with a heavy resistance-training program may confer benefits with regards to body composition. Furthermore, there is no evidence that consuming a high protein diet has any deleterious effects.

Prolonged Adaptation to a Low or High Protein Diet Does Not Modulate Basal Muscle Protein Synthesis Rates - A Substudy.

BackgroundBased on controlled 36 h experiments a higher dietary protein intake causes a positive protein balance and a negative fat balance. A positive net protein balance may support fat free mass accrual. However, few data are available on the impact of more prolonged changes in habitual protein intake on whole-body protein metabolism and basal muscle protein synthesis rates.ObjectiveTo assess changes in whole-body protein turnover and basal muscle protein synthesis rates following 12 weeks of adaptation to a low versus high dietary protein intake.MethodsA randomized parallel study was performed in 40 subjects who followed either a high protein (2.4 g protein/kg/d) or low protein (0.4 g protein/kg/d) energy-balanced diet (30/35/35% or 5/60/35% energy from protein/carbohydrate/fat) for a period of 12 weeks. A subgroup of 7 men and 8 women (body mass index: 22.8±2.3 kg/m2, age: 24.3±4.9 y) were selected to evaluate the impact of prolonged adaptation to either a high or low protein intake on whole body protein metabolism and basal muscle protein synthesis rates. After the diet, subjects received continuous infusions with L-[ring-2H5]phenylalanine and L-[ring-2H2]tyrosine in an overnight fasted state, with blood samples and muscle biopsies being collected to assess post-absorptive whole-body protein turnover and muscle protein synthesis rates in vivo in humans.ResultsAfter 12 weeks of intervention, whole-body protein balance in the fasted state was more negative in the high protein treatment when compared with the low protein treatment (-4.1±0.5 vs -2.7±0.6 μmol phenylalanine/kg/h;P<0.001). Whole-body protein breakdown (43.0±4.4 vs 37.8±3.8 μmol phenylalanine/kg/h;P<0.03), synthesis (38.9±4.2 vs 35.1±3.6 μmol phenylalanine/kg/h;P<0.01) and phenylalanine hydroxylation rates (4.1±0.6 vs 2.7±0.6 μmol phenylalanine/kg/h;P<0.001) were significantly higher in the high vs low protein group. Basal muscle protein synthesis rates were maintained on a low vs high protein diet (0.042±0.01 vs 0.045±0.01%/h;P = 0.620).ConclusionsIn the overnight fasted state, adaptation to a low-protein intake (0.4 g/kg/d) does not result in a more negative whole-body protein balance and does not lower basal muscle protein synthesis rates when compared to a high-protein intake.Trial RegistrationClinicaltrials.gov NCT01551238.

12. Remission of Impaired Glucose Tolerance (IGT) to Normal Glucose Tolerance (NGT) in Obese Adults with High Protein vs. High Carbohydrate Diet (90-OR)

The purpose of this study is to identify a diet that facilitates weight loss and conversion of patients with impaired glucose tolerance (IGT) to normal glucose tolerance (NGT). Specific aim was to determine if a High Protein (HP) or High Carbohydrate (HC) diet is more effective in conversion of IGT obese adults to NGT. 18 obese, pre-diabetic adults were randomized to a HP or HC diet for 6 months (mo) with all food provided. The HP diet consisted of 30% protein, 30% fat, 40% carbohydrates while the HC diet consisted of 15% protein, 30% fat, 55% carbohydrates distributed by percentage of daily kcals derived for each subject. An Oral Glucose Tolerance Test (OGTT) was performed at Baseline (BL) and 6 mo to determine IGT/NGT status. A 2 hr glucose between 140 to 199 mg/dl was considered IGT. DXA was done at BL and 6 mo. Food pick up and weight checks were weekly. Both diet groups had weight loss, improvement in insulin sensitivity determined by HOMA IR [HP (BL 4.69 ± 0.26; 6 mo 1.58 ± 0.14)], [HC (4.62 ± 0.26; 6 mo 3.15 ± 0.27)] and decrease in HbA1c [HP (BL 5.99 ± .05; 6 mo 5.53 ± .02)], [HC (BL 5.9 ± .04; 6 mo 5.69 ± .06)]. The HP diet had a 100% (9/9) conversion rate to NGT while the HC diet had a 44.4% (4/9) conversion rate. HP group had a 2.8 ± .4% increase in lean body mass and 2.5 ± 0.4% decrease in fat mass while the HC group had a 2.1 ± 1.1% and 3.5 ± 0.9 % decrease in lean and fat mass with greater overall average weight loss. Both diets resulted in improvement in glucose tolerance and insulin sensitivity but the HP diet was most effective. Our results suggest that lean body mass preservation may be more important than total weight loss in the conversion of IGT to NGT, possibly due to the high insulin sensitivity of muscle cells.

A high‐protein breakfast prevents body fat gain, through reductions in daily intake and hunger, in “Breakfast skipping” adolescents

The purpose of this study was to examine whether the daily consumption of normal-protein (NP) vs. high-protein (HP) breakfast meals improves appetite control, food intake, and body composition in "breakfast skipping" young people with overweight/obesity. Fifty-seven adolescents (age: 19 ± 1 years; BMI: 29.7 ± 4.6 kg m(-2)) completed a 12-week randomized controlled trial in which the adolescents consumed either a 1,464 kJ NP breakfast (13 g protein) or a HP breakfast (35 g protein) or continued to skip breakfast (CON). Pre- and post-study appetite, food intake, body weight, and body composition were assessed. Time-by-group interactions (P < 0.05) were detected for body fat mass, daily intake, and perceived hunger. Specifically, HP prevented fat mass gains over the 12 weeks (-0.4 ± 0.5 kg) vs. CON (+1.6 ± 0.9 kg; P = 0.02), whereas NP did not (+0.3 ± 0.5 kg). HP led to reductions in daily intake (-1,724 ± 954 kJ) vs. CON (+1,556 ± 745 kJ; P = 0.03), whereas NP did not (+494 ± 213 kJ). Lastly, only the HP group experienced reductions in daily hunger vs. CON (P < 0.05). However, when directly comparing the HP vs. NP groups, no differences were detected in any outcomes. The daily addition of a HP breakfast improved indices of weight management as illustrated by the prevention of body fat gain, voluntary reductions in daily intake, and reductions in daily hunger in breakfast skipping adolescents with overweight/obesity.

Fast-digestive protein supplement for ten days overcomes muscle anabolic resistance in healthy elderly men

Adequate protein intake is crucial to maintain muscle protein content in elderly subjects, but quality of dietary proteins should be considered. The aim was to determine whether soluble milk protein offers an original strategy to increase muscle anabolism in elderly subjects via a synergistic effect of fast-digesting proteins together with a unique essential AA content. We investigated the effect of a 10-day adequate-protein (AP) or high-protein (HP) diet together with the protein source as caseins (CAS) or soluble milk proteins (PRO) on specific muscle protein fractional synthesis rates (FSRs) in healthy elderly men (71.8±2.4yr, n=31). The isotopic study consisted of two periods of 4h each: a post-absorptive and a postprandial period. The fed state was defined by consumption of either 15g or 30g of PRO or CAS, given fractionally every 20min for 4h. Soluble milk proteins are produced using a membrane process directly from pasteurized milk. Specific muscle protein FSRs were measured during both postabsorptive and postprandial period using a continuous infusion of l-[1-(13)C]leucine. FSR of sarcoplasmic muscle proteins and actin did not increase significantly in the postprandial state compared to postabsorptive state, whereas myosin FSR rate was increased by feeding whatever the protein source in HP groups (0.024±0.005 vs 0.053±0.011%h(-1), P<0.05 and 0.026±0.004 vs 0.050±0.005%h(-1), P<0.004 for PRO HP and CAS HP) but only with the PRO meal in the AP groups (0.031±0.003 vs 0.062±0.009%h(-1), P<0.03 for PRO AP). Mitochondrial muscle protein FSR was also increased by feeding, irrespective of the protein quantity, but only in PRO meal groups (P<0.02). Fast-digesting soluble milk proteins improved postprandial muscle protein synthesis, especially mitochondrial muscle proteins and myosin fractional synthesis rates, in elderly subjects.

Relationship between seminal plasma tuberoinfundibular peptide of 39 residues and sperm functional attributes in buffalo (Bubalus bubalis).

The buffalo seminal plasma protein profile and its relationship with sperm quality have not been studied in detail. Thus, the aim of the present study was to profile buffalo seminal plasma proteins and to assess the relationship between differentially expressed proteins and sperm characteristics. Semen samples (n = 44) were collected from 11 Murrah buffalo bulls (four ejaculates from each animal) and seminal plasma protein profiling was performed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Matrix-assisted laser desorption ionisation time-of-flight analysis of one of the differentially expressed proteins, namely the 11-12 kDa protein, identified it as tuberoinfundibular peptide of 39 residues (TIP39). Western blot analysis confirmed the presence of TIP39, with TIP39 expression in seminal plasma varying among bulls. Based on TIP39 levels, bulls were classified into two groups, those with high and low protein. The percentages of spermatozoa positive for mitochondrial membrane potential test, chromatin distribution test, synthetic media sperm penetrability test and acrosomal integrity test were significantly (P < 0.05) high in the high protein group. The present study is the first to demonstrate the presence of TIP39 in buffalo seminal plasma and the positive effect of TIP39 on the functional parameters and fertilising ability of spermatozoa.

High Protein (HP) and Balanced Diets (BD) Lead to Weight Loss and Increase of Serum Adiponectin in Obese and Overweight Women at Aerobic Gyms: A Randomized Clinical Trial

This trial aimed to assess the effects of high protein (HP) (45% carbohydrate, 25% protein, and 30% fat) and balanced diets (BD) (55% carbohydrate, 15% protein, and 30% fat) on weight loss and plasma adiponectin levels in overweight and obese women who do aerobic activity. A parallel double blinded randomized clinical trial. Demographic data were collected at baseline. Body weight and adiponectin levels were measured at the baseline and after eight weeks of intervention. We used SPSS software for data analyzing and Nutritionist IV for analyzing dietary intakes. The study was an eight-week trial that consisted of 56 women with BMI ≥ 25kg/m<SUP>2</SUP>, aged 20-46 years who were randomly assigned to intervention. Body weight with adherence to HP and BD diets decreased significantly, however; the reduction in the HP group was more than the BD group (P<0.001 in both groups). Adiponectin significantly increased in HP and BD (P=0.001 and p<0.001 respectively). These changes did not significantly differ between the two groups. In conclusion, our trial showed that high protein and balanced diets resulted in desirable effects on body weight and on circulating adiponectin during the eight weeks.

Immune Potentiating role of Protein, Probiotic and Symbiotic Supplementation in Moulted White Leghorn Hens

This study investigated the effects of high protein, probiotic and symbiotic supplementation on the immunity of culled moulted White Leghorn hens. Cage-housed hens ( n = 240) aged about 70 weeks were moulted by including zinc in the diet. The moulted hens were randomly divided in four treatment groups: control group (G1; CP 16% in basal diet), high protein group (G2; CP 18% in basal diet), probiotic supplemented group (G3; symbiotic at a dose rate of 85 mg L−1 in drinking water + CP 16% in basal diet), and symbiotic group (G4; probiotic at a dose rate of 85 mg L−1 in drinking water + CP 16% in basal diet). Ten birds from each group were euthanised at 5% peak (5P), full peak (FP), and end of production (EP). Blood samples were taken for serum to estimate geometric mean antibody titre (GMT) against Newcastle disease virus (NDV) and egg drop syndrome (EDS) virus. Macrophages were isolated from abdominal exudates (AE) to observe their engulfment response and their nitric oxide (NO) production. 2,4-Dinitrochlorobenzene (DNCB) was inoculated on the skin of five birds in each group to evaluate the delayed type hypersensitivity response by determining the skin thickness. The overall humoral antibody GMT against NDV in the groups was higher in G2, G3 and G3 compared to G1. GMT value against EDS was higher in G2 compared to G1. A significant increase ( P ≤ 0.01) in macrophage engulfment and NO production was seen in G2 and G4 compared to the G1. The DNCB inoculated skin thickness response remained higher ( P ≤ 0.01) in G2 until FP than the other groups. A diet rich in protein or supplemented with a probiotic or a symbiotic enhances the body immunity of moulted hens.